EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Zonula occludens 1 as a novel biomarker in decompensated alcoholic cirrhosis with hepatorenal syndrome

Balasubramaniyan Vairappan, Raj Kumar, Mukta Wyawahare

Exploration of Digestive Diseases · 2025

DOI: 10.37349/edd.2025.100574 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Exploration of Digestive Diseases, 2025. Verfasst von Balasubramaniyan Vairappan und 2 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Our previous study provided evidence that systemic zonula occludens (ZO) 1 levels are elevated in cirrhotic and hepatocellular carcinoma (HCC) patients. Here, we aimed to evaluate serum ZO-1 levels in patients with decompensated alcoholic cirrhosis (DCAC) with hepatorenal syndrome (HRS) and compare its diagnostic potential with the well-established HRS biomarker, cystatin C.

Methods

A total of 36 DCAC patients with HRS and 40 healthy volunteers were recruited. Serum ZO-1, cystatin C, and clinical chemistry parameters were analysed.

Results

Compared to control subjects, DCAC patients with HRS exhibited significantly higher ZO-1 levels (7.059 ± 0.29 vs. 0.788 ± 0.11; p < 0.0001) and cystatin C levels (2.97 ± 0.24 vs. 1.59 ± 0.04; p < 0.0001). Serum ZO-1 correlated positively with cystatin C (r = 0.561, p < 0.0001), serum creatinine (r = 0.779, p < 0.0001), and MELD-Na (r = 0.850, p < 0.0001). Moreover, ZO-1 demonstrated a higher area under the curve (AUC) than cystatin C, indicating a better diagnostic potential for HRS in DCAC patients.

Conclusions

These findings suggest that ZO-1 may serve as a valuable biomarker for HRS in DCAC patients. However, further validation in a larger cohort is necessary to confirm its clinical utility.

Zitieren

APA

Vairappan, B., Kumar, R., & Wyawahare, M. (2025). Zonula occludens 1 as a novel biomarker in decompensated alcoholic cirrhosis with hepatorenal syndrome. Exploration of Digestive Diseases. https://doi.org/10.37349/edd.2025.100574

Vancouver

Vairappan B, Kumar R, Wyawahare M. Zonula occludens 1 as a novel biomarker in decompensated alcoholic cirrhosis with hepatorenal syndrome. Exploration of Digestive Diseases. 2025. doi:10.37349/edd.2025.100574

BibTeX
@article{Vairappan2025,
  author = {Vairappan, Balasubramaniyan and Kumar, Raj and Wyawahare, Mukta},
  title = {Zonula occludens 1 as a novel biomarker in decompensated alcoholic cirrhosis with hepatorenal syndrome},
  journal = {Exploration of Digestive Diseases},
  year = {2025},
  doi = {10.37349/edd.2025.100574}
}
Kostenlos starten →